Evaluation of the Hybrid Rapid Maxillary Expander Assisted With Micro-osteo Perforation (MOPs) in… (NCT06467240) | Clinical Trial Compass
CompletedNot Applicable
Evaluation of the Hybrid Rapid Maxillary Expander Assisted With Micro-osteo Perforation (MOPs) in Adult.
Egypt14 participantsStarted 2024-10-01
Plain-language summary
This study will be directed for Evaluation of the hybrid rapid maxillary expander assisted with Micro-osteo perforation (MOPs) in adults
Who can participate
Age range17 Years – 23 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* An age range from 17-23 years.
* Transverse maxillary deficiency.
* Maxillary lingual Cross bite (unilateral or bilateral)
* No history of previous orthodontic treatment.
* Good oral and general health.
* No systemic condition that could interfere with orthodontic treatment.
Exclusion Criteria:
* Patient with craniofacial anomalies .
* History of extraction of permanent teeth.
* Previous orthodontic treatment.
* Poor oral hygiene or periodontally compromised patient.
* Previous history of bruxism, trauma or par functions.